Cargando…
Inter-organ Communication Pathway Manifested by Non-physiological Stress to the Kidney in Type II Diabetic Patients -Why Are Diabetic Patients Prone to Develop Heart Failure?
It has become clear that sodium glucose cotransporter (SGLT)-2 inhibitors not only do not increase the incidence of cardiovascular events but they also reduce the duration of hospitalization for heart failure in type 2 diabetes mellitus (T2DM) patients. The administration of SGLT2 inhibitor in T2DM...
Autor principal: | Sano, Motoaki |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Japanese Society of Internal Medicine
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6995696/ https://www.ncbi.nlm.nih.gov/pubmed/31178515 http://dx.doi.org/10.2169/internalmedicine.2870-19 |
Ejemplares similares
-
Anti-Diabetic Agents and Heart Failure ― Response to the CARMELINA Study ―
por: Sano, Motoaki
Publicado: (2018) -
A Paradigm Shift in the Treatment of Type 2 Diabetes and Heart Failure
por: Sano, Motoaki
Publicado: (2020) -
Deranged Myocardial Fatty Acid Metabolism in Heart Failure
por: Yamamoto, Tsunehisa, et al.
Publicado: (2022) -
Prone position in ARDS patients: why, when, how and for whom
por: Guérin, Claude, et al.
Publicado: (2020) -
Clinical and Biochemical Characteristics and Treatment Outcomes of Ketosis-Prone Diabetes: The Remission Prone Diabetes
por: Waddankeri, Swaraj Shrikant, et al.
Publicado: (2021)